Upper Extremity Rehabilitation Using Robot and Botulinum Toxin
NCT ID: NCT02228863
Last Updated: 2014-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
348 participants
INTERVENTIONAL
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Inmotion and Botox
Concomitant use of Inmotion and botulinum toxin from the baseline
Early Inmotion and Botox
Concomitant use of Inmotion and Botox from the baseline
Botox, then Inmotion
Inmotion training 4 weeks after botulinum toxin injection
Botox, then Inmotion
At baseline Botox injection and 4 weeks after Inmotion
Inmotion, then Botox
From the baseline Inmotion, then Botox injection at 4 weeks after baseline
Inmotion, then Botox
Inmotion from the baseline, then Botox injection at 4 weeks after baseline
Late Inmotion and Botox
No intervention, then Inmotion and Botox injection at 4 weeks from the baseline
Late Inmotion and Botox
No intervention until 4 weeks from the baseline. Then Inmotion and Botox injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early Inmotion and Botox
Concomitant use of Inmotion and Botox from the baseline
Botox, then Inmotion
At baseline Botox injection and 4 weeks after Inmotion
Inmotion, then Botox
Inmotion from the baseline, then Botox injection at 4 weeks after baseline
Late Inmotion and Botox
No intervention until 4 weeks from the baseline. Then Inmotion and Botox injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Shoulder or Elbow flexor spasticity above or modified ashworth scale 1+
* Cognitively intact enough to understand and follow the instructions from the investigator
Exclusion Criteria
* Fracture of affected upper limb
* Recent history of botulinum toxin injection within 6 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Rehabilitation Center, Seoul, Korea
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joon-Ho Shin
Team manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joon-Ho Shin, MS
Role: PRINCIPAL_INVESTIGATOR
National Rehabilitation Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Rehabilitation Center
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Joon-Ho Shin, MS
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Shin JH, Park G, Kim H, Cho DY, Kwon S. Combined effects and timing of robotic training and botulinum toxin on upper limb spasticity and motor function: a single-blinded randomized controlled pilot study. J Neuroeng Rehabil. 2025 Mar 6;22(1):50. doi: 10.1186/s12984-025-01584-1.
Related Links
Access external resources that provide additional context or updates about the study.
Site of the present study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NRC-2014-01-005
Identifier Type: -
Identifier Source: org_study_id